Endometrioid adenocarcinoma arising in endometriosis foci six years after estrogen replacement therapy: a case report.
We present a case of a 53-year-old woman who developed an endometrioid adenocarcinoma six years after total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO), who was on estrogenic-only hormone replacement therapy (HRT).
Areia
A
A
Department of Gynecology, Coimbra University Hospital, Portugal.
Sousa
V
V
Frutuoso
C
C
Dias
I
I
Martins
M I
MI
de Oliveira
C F
CF
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018269:Carcinoma, Endometrioid / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D004715:Endometriosis / Q000473:pathology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary; D014592:Uterine Hemorrhage / Q000209:etiology; D014625:Vaginal Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
D004317:Doxorubicin; D002945:Cisplatin